Total planned funding: $462,701,031
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $67,016,940 |
Nigeria | $64,298,944 |
South Africa | $58,599,727 |
Zambia | $41,190,737 |
Asia Regional Program | $35,475,616 |
Kenya | $19,975,454 |
Burundi | $19,117,164 |
Vietnam | $18,377,779 |
Zimbabwe | $18,045,078 |
Ethiopia | $17,777,012 |
West Africa Region | $13,460,980 |
Haiti | $11,375,317 |
Tanzania | $8,085,139 |
Malawi | $7,961,263 |
Dominican Republic | $7,551,779 |
Ghana | $6,982,500 |
enumerations.Philippines | $6,341,584 |
Côte d'Ivoire | $6,252,001 |
Botswana | $6,060,020 |
Democratic Republic of the Congo | $5,159,501 |
India | $4,050,000 |
Lesotho | $4,045,857 |
Eswatini | $3,810,687 |
South Sudan | $2,868,967 |
Rwanda | $2,594,238 |
Indonesia | $2,075,000 |
Uganda | $1,945,454 |
Namibia | $1,497,275 |
Western Hemisphere Region | $709,018 |
Cambodia | $0 |
Organizational Types
NGO | $462,701,031 |
Program Areas
Care | $146,735,206 |
Prevention | $116,927,701 |
Treatment | $114,154,330 |
Testing | $46,409,039 |
Governance and Systems | $38,474,755 |
Budget Codes
HTXS: Treatment: Adult Treatment | $99,005,567 |
HKID: Care: Orphans and Vulnerable Children | $81,883,089 |
HVOP: Sexual Prevention: Other Sexual Prevention | $61,873,166 |
HBHC: Care: Adult Care and Support | $47,041,328 |
HVCT: Testing: HIV Testing and Counseling | $46,409,039 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,034,248 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,639,174 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,235,633 |
OHSS: Health Systems Strengthening | $12,910,491 |
HVSI: Strategic Information | $12,849,262 |
HLAB: Laboratory Infrastructure | $12,715,002 |
PDTX: Treatment: Pediatric Treatment | $10,066,649 |
HVTB: Care: TB/HIV | $9,349,026 |
PDCS: Care: Pediatric Care and Support | $8,461,763 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,632,003 |
HMIN: Biomedical Prevention: Injection Safety | $369,074 |
HMBL: Biomedical Prevention: Blood Safety | $144,403 |
Top Partner Programs
FHI 360:
$462,701,031
View countries